Symetis ACURATE TF™ aortic bioprosthesis
Copyright policy ) Alexandre Abizaid; Eberhard Grube; Patrick Diemert; Jörg Kempfert; Stephan Baldus; Helge Möllmann;
Symetis ACURATE TF™ aortic bioprosthesis
Aged, 80 and over, Bioprosthesis, Heart Valve Prosthesis Implantation, Cardiac Catheterization, Incidence, Aortic Valve Insufficiency, Aortic Valve Stenosis, Prosthesis Design, Femoral Artery, Treatment Outcome, Aortic Valve, Heart Valve Prosthesis, Alloys, Humans
Aged, 80 and over, Bioprosthesis, Heart Valve Prosthesis Implantation, Cardiac Catheterization, Incidence, Aortic Valve Insufficiency, Aortic Valve Stenosis, Prosthesis Design, Femoral Artery, Treatment Outcome, Aortic Valve, Heart Valve Prosthesis, Alloys, Humans
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).68 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 68
Top 10%
Top 10%
Top 10%
Fields of Science
This action will publish the selected files and record in Zenodo. Are you sure you want to proceed?